Related Experiment Video
Updated: Oct 14, 2025

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Nrf2/Keap1/ARE signaling: Towards specific regulation
Alexey V Ulasov1, Andrey A Rosenkranz2, Georgii P Georgiev1
1Department of Molecular Genetics of Intracellular Transport, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia.
Abstract:
The Nrf2 transcription factor governs the expression of hundreds genes involved in cell defense against oxidative stress, the hallmark of numerous diseases such as neurodegenerative, cardiovascular, some viral pathologies, diabetes and others. The main route for Nrf2 activity regulation is via interactions with the Keap1 protein. Under the normoxia the Keap1 binds the Nrf2 and targets it to the proteasomal degradation, while the Keap1 is regenerated. Upon oxidative stress the interactions between Nrf2 and Keap1 are interrupted and the Nrf2 activates the transcription of the protective genes. Currently, the Nrf2 system activation is considered as a powerful cytoprotective strategy for treatment of different pathologies, which pathogenesis relies on oxidative stress including viral diseases of pivotal importance such as COVID-19. The implementation of this strategy is accomplished mainly through the inactivation of the Keap1 "guardian" function. Two approaches are now developing: the Keap1 modification via electrophilic agents, which leads to the Nrf2 release, and direct interruption of the Nrf2:Keap1 protein-protein interactions (PPI). Because of theirs chemical structure, the Nrf2 electrophilic inducers could non-specifically interact with others cellular proteins leading to undesired effects. Whereas the non-electrophilic inhibitors of the Nrf2:Keap1 PPI could be more specific, thereby widening the therapeutic window.
Insights
The Nrf2-Keap1 pathway regulates cellular defense against oxidative stress. Inhibiting Keap1 can activate Nrf2 for treating diseases like COVID-19, with non-electrophilic inhibitors offering greater specificity.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- The Nrf2 transcription factor controls genes vital for combating oxidative stress, a key factor in diseases like neurodegeneration, cardiovascular conditions, diabetes, and viral infections.
- Nrf2 activity is primarily regulated by its interaction with the Keap1 protein, which targets Nrf2 for degradation under normal conditions but releases it during oxidative stress to activate protective genes.
Purpose of the Study:
- To explore the therapeutic potential of activating the Nrf2 system for treating oxidative stress-related diseases, including viral infections like COVID-19.
- To evaluate strategies for inactivating the Keap1 protein's regulatory function on Nrf2.
Main Methods:
- Investigating two primary approaches to Nrf2 system activation: modification of Keap1 via electrophilic agents and direct interruption of Nrf2:Keap1 protein-protein interactions (PPI).
- Comparing the specificity and potential side effects of electrophilic inducers versus non-electrophilic inhibitors of Nrf2:Keap1 PPI.
Main Results:
- Electrophilic agents targeting Keap1 may cause non-specific interactions with other cellular proteins, potentially leading to adverse effects.
- Non-electrophilic inhibitors of Nrf2:Keap1 PPI demonstrate higher specificity, suggesting a broader therapeutic window.
Conclusions:
- Activating the Nrf2 pathway is a promising strategy for treating various pathologies linked to oxidative stress.
- Non-electrophilic inhibitors of Nrf2:Keap1 PPI represent a potentially safer and more effective therapeutic approach compared to electrophilic inducers.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of the Unfolded Protein Response
Regulation of Nuclear Protein Sorting
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

